Although DKK1 has been proven to be a good predictor of TACE treatment efficacy and prognosis in HCC patients in previous studies [27], NDRG1 has not been found to be associated with TACE responsiveness in previous studies, and it has a role in the prognosis of HCC patients. This evidence concerns the gene DKK1 and hepatocellular carcinoma.